Product information

Current status:

Cancelled Post Market

Current status date:

2005-08-04

Original market date: ^{See footnote 1}

1999-06-28

Product name:

NOVOLINSET GE NPH INJ SUS 100U/ML

DIN:

02024403 Electronic product monograph is not available

Company:

NOVO NORDISK A/S
Novo Alle
Bagsvaerd
--
Denmark 2880

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

68:20.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

A10AC01 INSULIN (HUMAN)

Active ingredient group (AIG) number:^{See footnote5}

0123341001